News

Travel Lake Anna might look like a typical travel agency dedicated to promoting vacations around Lake Anna, a state park located in Virginia. However, the company has a unique business model and purpose. Husband and wife team Chris and Laura Denkers created and manage the company in support of their two sons who were…

AffloVest, a wearable, self-contained oscillation vest device from International Biophysics that helps patients with Cystic Fibrosis breathe easier, was previously backed by numerous patient testimonies and is now proven in a new Clinical Study that it increased forced expiratory volume in one second (FEV1) an average…

A study led by researchers at the University of Szeged in Hungary recently revealed that excessive alcohol consumption impairs the function of the defective gene in cystic fibrosis (CF) leading to pancreatitis. The study was published in the journal Gastroenterology and is entitled “Alcohol…

A team led by researchers at the University Hospital in Strasbourg, France is currently recruiting patients for a clinical trial designed to assess the efficacy of combined lung and pancreatic islet transplantation in individuals with end-stage cystic fibrosis (CF). The trial is entitled “Metabolic…

Researchers at the University of Michigan Medical School recently published in the journal Microbiome findings indicating that lung microbiota alterations observed during disease onset in individuals with cystic fibrosis may become useful as predictors of exacerbations. The study is entitled “The daily dynamics of…

An article published in BioMed Central’s Pulmonary Medicine journal provides evidence that the impaired immune system, a key feature in cystic fibrosis (CF), may lead to patients being deprived of necessary oxygen due to lung tissue destruction. The study, entitled “Hypoxia down-regulates expression…

Biopharmaceutical company Aridis Pharmaceuticals, Inc. has named Paul-Andre de Lame, MD as its new chief medical officer to help the company in their efforts to develop new anti-infective and immune therapies to treat infectious diseases. Aridis is currently developing a reactive monoclonal antibody drug called Aerucin, to treat Pseudomonas aeruginosa associated with cystic fibrosis.

AbbVie recently announced that the 2015 AbbVie CF Scholarship is now open and accepting applications from both graduate and undergraduate students. This scholarship supports and honors young adults suffering with cystic fibrosis (CF) in their pursuit of higher education. Students can apply for the scholarship until May 27, 2015, 10 a.m. (central…

Just Breathe: Adults living with Cystic Fibrosis is a newly released book that captures the human experience of Cystic Fibrosis through a series of simple, yet complex portraits of adults living with the disease. Readers will find themselves transfixed as each page brings a new face, challenging…

In a new study entitled “Ultrasound echo-intensity predicts severe pancreatic affection in cystic fibrosis patients,” the authors suggest ultrasonography is a suitable and effective diagnostic tool to evaluate pancreatic function in cystic fibrosis patients. The findings could help physicians better diagnose and treat the pancreatic issues and…